Trending Now
Commercial Investor's Corner Slingshot Capital Special Features

Covid-19 and Defendant Collectability Risk

April 15, 2020

Covid-19 and Defendant Collectability Risk

The following article is part of an ongoing column titled ‘Investor Insights.’  Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance.  EXECUTIVE SUMARY
  • Covid-19 will likely lead to the biggest financial crisis since the Great Depression
  • The crisis has affected the solvency and viability of corporations and sovereigns
  • Litigation managers need to re-assess collectability risk, immediately and regularly, of each defendant in their portfolio
INVESTOR INSIGHTS
  • Diligencing litigation managers should involve a deep understanding of how they assess defendant collectability risk
  • Defendant collectability risk is an ongoing risk that changes over time, therefore managers need a continuous risk assessment methodology
  • Investors looking to invest in litigation finance secondaries to take advantage of the current dislocation should avoid single case risk and look to portfolio acquisitions, but must assess collectability risk across the portfolio being acquired
As Covid-19 has taken the planet and the legal community by surprise, I think there are some lessons learned from private equity that can be applied to litigation finance.  In short, focus on cash – its collection, generation, distribution and availability. So, how does this relate to Litigation Finance? This novel Coronavirus-driven healthcare crisis which has spiralled into a broad-based economic crisis, the likes of which the modern global economy hasn’t seen since the Great Depression, has had the effect of taking otherwise viable, profitable and cashflow positive businesses and stopping them in their tracks.  Overnight, certain businesses and industries have performed a complete one-eighty, whereby they went from solvent to being on the precipice of insolvency.  For many litigation finance firms, their immediate reaction has and should be to undertake an immediate and urgent review of the defendants involved in each and every case in which their portfolios have an investment, in order to re-assess collectability risk, one of the key areas of litigation finance underwriting. When an economy, especially a consumer driven economy like the US, effectively shuts down overnight, there are few industries and companies that will be spared from a diminution in their value and blockage from access to capital.  Former “recession-resistant” and “necessity” businesses have just experienced a new reality, which is that necessity is determined by context.  The current context states that the only necessity is feeding, hand washing, shelter and healthcare, and this has had a massive impact on the economy. While this too shall pass, the economic impacts will likely linger for a number of months and years.  The hope for a “V” shaped recovery has been dashed, as the crisis has extended beyond initial duration estimates.  My personal opinion is that it will at best look like a “U” shaped recovery with the possibility of a double “W”, meaning there will likely be some ups and downs along the way, should the dreaded “C-19” rear its ugly head again going into the next flu season, or should it fail to be contained due to premature ‘return to daily activity’ policy.  My hope is that the massive amounts of stimulus that are being pumped into the global economy actually make their way to the most hard-hit regions of the economy, namely ‘Mainstreet’, and thereby mitigate the damage that would otherwise be experienced for many small and medium-sized businesses on which most economies rely. While we tend to focus on home first, litigation funders should also be mindful that the economy is global.  As bad as developed countries think they may have it, fund managers who participate in the international arbitration market, which by definition, involve developing countries and corporations therein, need to be mindful that those defendants in developing countries will likely be even more greatly affected. Yes, even sovereigns. Those managers that are focused on patent litigation involving start-up technology companies should also ensure the plaintiff is solvent through the end of the litigation, not to mention the collectability risk of the defendant, which may have been negatively impacted. All of this is to say, that it is in the best interests of litigation finance managers to undertake a re-assessment of collectability risk of each and every defendant in their portfolio, and to do so on a regular basis for the foreseeable future.  Managers will need to assess (i) the degree to which the defendant’s industry has been impacted, (ii) the strength of each defendant’s business and balance sheet, (iii) the ability for the defendant (business or sovereign) to access sufficient capital to maintain solvency, (iv) the degree to which the value of such business has declined, (v) a study of the defendants’ behaviour during the last economic crisis, as it relates to litigation ongoing at that time, if any, (vi) determine the extent to which other parties have security and seniority ahead of the plaintiff’s claims and (vii) assess the defendants’ ability to raise capital outside of financing (i.e. asset sales, equity raises, etc.). Once a determination has been made as to the relative collectability risk, managers will then need to determine next steps with respect to protecting themselves from those cases where the defendant collectability risk has materially changed.  This may involve the withdrawal of any further financing provisions (to the extent the financing was milestone-based), partnering with other parties to share the increased risk of the case, or selling all or a portion of a case or a portfolio (although the manager would be selling into a weak secondary market with relatively few participants, which will be reflected in the valuation, if they can secure bids).  While the options may not be great, they may be better than investing ‘good money after bad’. Investor Insights For investors that are invested in the sector or considering making an investment in the litigation finance market, now is a good time to diligence how and the extent to which managers were on top of their portfolio in assessing collectability risk.  For those investors interested in secondary market opportunities, caveat emptor.  The risk profile for a single case secondary is much higher given the high level of uncertainty in today’s market so a portfolio of secondaries may be a better risk-adjusted avenue to pursue but the portfolio’s diversification benefits would not negate the need to reassess the collectability risk of each defendant in the portfolio.  Edward Truant is the founder of Slingshot Capital Inc., and an investor in the consumer and commercial litigation finance industry.

Commercial

View All
Commercial

Zurich’s Quarterly U.S. Lobbying Spend Climbs to $660,000 With Funding Disclosure Bill Pending

Zurich American Insurance Company increased its federal lobbying expenditure in the third quarter of 2026, with the Litigation Transparency Act of 2025 among the measures listed in its disclosures.

As reported by Legis1, Zurich reported $550,000 in in-house lobbying expenses for the quarter, supplemented by $60,000 paid to Invariant LLC and $50,000 to Tiber Creek Group Inc. The combined total of $660,000 is $70,000 above the insurer's second-quarter figure of $590,000.

H.R.1109 would require parties in a civil action to disclose any person, other than counsel, holding a contingent right to receive payment based on the outcome of the case, and to produce the underlying funding agreement. The bill was referred to the House Judiciary Committee in February 2025 and its most recent recorded action remains the committee consideration and markup sessions held in November 2025. Its cosponsor count has grown from two at introduction to 28 as of June 2026.

The measure has drawn broad support from the property and casualty sector. A U.S. Chamber of Commerce coalition letter backing the bill was signed by Zurich North America alongside Allstate, Chubb, Liberty Mutual, State Farm and Travelers, as well as the American Property Casualty Insurance Association and the National Association of Mutual Insurance Companies.

Opposition has come from an unexpected direction. Tea Party Patriots Action has urged the House Judiciary Committee to reject the bill, and a donor-privacy coalition including PDE Action has argued it would compel disclosure of private financial arrangements outside the ordinary discovery process without any judicial finding of relevance.

Commercial

ATE Insurers Expected to Await Manchester City Appeal Before Backing Compensation Claims

Rival clubs, players and agents weighing compensation claims against Manchester City may struggle to secure after-the-event insurance until the club's appeal is resolved, according to a specialist litigation insurance underwriter.

As reported by Insurance Business, Rocco Pirozzolo, managing director and underwriting director at Harbour Underwriting, said the live appeal creates uncertainty that underwriters are unlikely to price. "With a live appeal, this creates uncertainty, and so I expect underwriters would want to wait for the outcome of the appeal," he said.

The Premier League announced on 29 September that an independent commission had found the club in breach of more than 100 of its rules, upholding 114 of the 115 charges brought in 2023 following an investigation that began in 2018. Manchester City lodged an appeal on 1 October and denies wrongdoing.

Pirozzolo noted that Burnley's earlier award against Everton gives underwriters a roadmap for this type of claim, but that tying a rule breach to lost results and lost revenue remains the difficult part. Causation and quantum are the key tests for ATE underwriters assessing whether a claim is insurable.

Arsenal, Liverpool, Manchester United and Tottenham are reported to have lodged notices in 2024 reserving the right to claim compensation, while players and agents are said to be exploring loss-of-earnings claims tied to bonus payments.

A three-member appeal board will hear the case and may dismiss or allow the appeal, remit it to the commission, or alter any sanction. Under Premier League rules the hearing should be held within 12 weeks of being lodged, with a decision due within 30 days of its conclusion.

Commercial

Omni Bridgeway Reports 3.9x MOIC on A$135.8m of First-Quarter Completions

Omni Bridgeway Limited (ASX: OBL) has reported that it is tracking at or above all of its FY27 operational targets, with first-quarter completions returning well above the funder's recent historical average.

As reported by GlobeNewswire, the alternative asset manager's Investment Portfolio Report as at 30 September 2026 records 20 full and partial completions generating A$135.8m in investment proceeds at a 3.9x multiple on invested capital. That compares with a two-year trailing average of 2.5x, and the completions converted at 102% of carrying fair value.

Management fees rose 24% year-on-year to A$10.7m, and the group received A$9.4m in cash carried interest, with a further A$8.6m accrued on Series II funds but not yet distributed. Omni Bridgeway also completed the final close of its Funds 4 and 5 Series II at the full US$1 billion target during the quarter, which it expects to push management fee growth towards the higher end of its indicated FY27 range.

New commitments totalled A$87.1m across nine new investments, up 23% on the prior corresponding quarter, adding A$81.2m in new fair value. The pipeline comprised 46 agreed exclusive term sheets representing an estimated A$416.6m in potential new commitments, up from A$317.8m a year earlier.

Cash operating expenses of A$15.7m tracked below the FY27 budget range of A$72.5m to A$75.0m, with a cost coverage ratio of 68% for the quarter. Chief Executive Officer Raymond van Hulst pointed to the 46 exclusive term sheets and a significant number of late-stage investments in the portfolio.